“But Revlimid is also, I soon learned, extraordinarily expensive, costing nearly $1,000 for each daily pill. (Although, I later discovered, a capsule costs just 25 cents to make.)”
Revlimid costs 25 cents to make and sells for nearly $1,000 a pill. Celgene raised the price 26 times and kept generics away with patents. Bristol Myers Squibb bought it and kept raising. Medicare paid $3.3 billion for it in one year.